The present invention relates to a compound which is an antagonist of ²8 integrin or an inhibitor of the expression of ²8 integrin for use in the treatment of resistant glioblastoma.
申请公布号
EP3009147(A1)
申请公布日期
2016.04.20
申请号
EP20140306644
申请日期
2014.10.16
申请人
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE);UNIVERSITÉ PAUL SABATIER (TOULOUSE III)
发明人
LEMARIE, ANTONY;MALRIC, LAURE;TOULAS, CHRISTINE;MOYAL, ELISABETH
